This book discusses the new era of modern retinal laser therapy and its clinical applications. While the photocoagulation era universally presupposed the therapeutic necessity of laser-induced retinal damage, the modern retinal laser therapy is equally opposed to this idea. The evidence for this sea-change in the understanding of retinal laser is well presented within this book, and the conceptual and clinical consequences are discussed with particular emphasis on the emergence of retinal laser therapy as the first reasonable preventive and restorative intervention for the most important retinal disorders. Finally, the future of modern retinal laser therapy is highlighted with respect to coming technological advances, remaining challenges, and the place of retinal laser in the management of retinal disease.
This book is an essential resource for all ophthalmic residents and clinicians seeking a clear and concise guide to modern retinal laser therapy in their everyday practice.
Andrzej Grzybowski, M.D., Ph.D., MBA, MAE is a Professor of Ophthalmology and Chair of the Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland; Head of Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland. He is active in international scientific societies including Euretina (Co-opted Board member 2016-2018), Retina Society,
AAO (International Fellow; member of the Global ONE Advisory Board 2017-2022, Museum of Vision’s Program Committee 2017-2022, and member of the Task Force On Myopia),
EVER (Board member and chair of the cataract section, 2019-2023;
President-Elect 2022-2023), ESCRS (curator of ESCRS Archive), and ISRS (member of the ISRS International Council), ISBCS, International Council of Ophthalmology (program coordinator for WCO in 2011-2018), and Cogan Society. He became a lifelong member (chair LIV) of the
European Academy of Ophthalmology and its Treasurer. He is a member of the Ophthalmic Education Consortium (OEC) advisory committee of the Ophthalmology Foundation and Academia Europea. He has been an active contributor to major ophthalmic conferences worldwide, including AAO (Achievement Award 2017, International Scholar Award 2018), APAO (International Coordinator 2017-2020, Achievement Award 2018), WCO (Program Coordinator 2010-2018), CCOS, Euretina, ESCRS, EVER, ISOPT, etc. He is the member of the Academia Europea.He has been an active editor, editor in chief, and author of more than 500 peer-reviewed international publications, and over 50 book chapters; reviewer for more than 20 journals. He is a
member of the editorial boards of many international journals, including the American Journal of Ophthalmology (IF 5.5),
Acta Ophthalmologica (IF 3.1), PLOS One (IF 3.75),
Graefe’s Archive for Clinical and Experimental Ophthalmology (IF 2,3),
Translational Vision Science & Technology (TVST), (IF 3.048), BMC Ophthalmology (2.086), Clinics in Dermatology (IF 2.797),
Journal of Clinical Medicine (IF 4.964),
Current Pharmaceutical Design (IF 2.94),
Frontiers in Neurology (IF 4.086), Asia Pacific Academy of Ophthalmology Jou
rnal (IF 4.206), Ophthalmology and Therapy (IF 4.9). Reviewer and member of Cochrane Collaboration.
As the only Polish ophthalmologist he was included in the TOP 2% ranking of world-best scientists prepared by Stanford University for 2019 and 2020. Expertscape worldwide ranking: No 1 in cataract field and No 1 in cataract extraction field. In 2021, he received ISRS (International Society for Refractive Surgery) Founders’ Award and published a book Artificial Intelligence in Ophthalmology (Springer). In 2022 he was awarded OFFICERS' CROSS OF THE ORDER OF POLONIA RESTITUTA for outstanding achievements in research and teaching, and support for international scientific cooperation by the President of Poland; listed on the “The Power List” by The Ophthalmologist magazine, a ranking of the Top 100 most influential people in the world of ophthalmology, and awarded by Marshal of Warmia and Mazury Region “The best of the best” recognition for scientific achievements.
Jeffrey K Luttrull M.D. is a consultant retina specialist and internationally recognized innovator in the treatment of retinal diseases. His contributions, including “high-density / low-intensity subthreshold diode microsecond pulsed laser” (SDM), are advancing the treatment and understanding of retinal disease. Dr Luttrull is the most published and most frequently cited author in the field of retinal laser treatment. Through his research, Dr. Luttrull has been a pioneer in early and preventive treatment of diabetic retinopathy and developer of first preventive treatments for age-related macular degeneration that reduce the riskof “wet” macular degeneration and slow progression of age-related geographic atrophy to reduce the risks of visual loss. This new approach to disease prevention is called “Vision Protection TherapyTM”, working via therapeutic Immunoactivation – engaging the body’s own immune system to safely and effectively reduce the risks of vision loss.
Dr. Luttrull is a life member of the American Academy of Ophthalmology; an “Honor Award” recipient of the American Society of Retinal Specialists; founder of the Ventura County Ophthalmology Society; the founder and executive director of LIGHT: The International Retinal Laser Society; and the founder and chief medical officer of the Vision Protection Institutes.
Igor Kozak MD, PhD is a consultant ophthalmic surgeon and clinical lead at Moorfields Eye Hospital Centre, Abu Dhabi, United Arab Emirates. Dr Kozak is a graduate of Pavol Jozef Šafárik University in Slovakia and is a fellowship-trained retina and uveitis specialist from the University of California San Diego Shiley Eye Institute, where he served on the retina faculty. He is currently a consultant ophthalmic surgeon and a clinical lead at the Moorfields Eye Hospital Centre in Abu Dhabi, United Arab Emirates, where he attends to patients with retinal and inflammatory problems and performs vitreoretinal surgery on adults and children.
Dr. Kozak’s academic interests include clinical research, ocular imaging, drug delivery, and pharmacology. He has participated in numerous clinical trials and has been principal investigator in some. He has published extensively in premier ophthalmic and scientific journals and has edited 6 ophthalmic books internationally. He serves as a scientific reviewer for more than 50 ophthalmology journals and is an editorial board member for 4 journals.
